GRANIX: FILGRASTIM INJECTION.
The FILGRASTIM INJECTION is a the manufacturer industrial component. Key specifications include administration: SUBCUTANEOUS, features_provided: STERILE, primary_container_type: SYRINGE, total_primary_container_quantity: 10, part_name_assigned_by_controlling_agency: FILGRASTIM INJECTION GRANIX. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-697-1746, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | SUBCUTANEOUS |
| features_provided | STERILE |
| primary_container_type | SYRINGE |
| total_primary_container_quantity | 10 |
| part_name_assigned_by_controlling_agency | FILGRASTIM INJECTION GRANIX |
| NSN | 6505-01-697-1746 |
| ADMINISTRATION | SUBCUTANEOUS |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | SYRINGE |
| SPECIAL FEATURES | THE PRODUCT IS A STERILE, CLEAR, COLORLESS, PRESERVATIVE-FREE SOLUTION CONTAINING TBO-FILGRASTIM, GLACIAL ACETIC ACID, SORBITOL, POLYSORBATE 80, SODIUM HYDROXIDE, AND WATER FOR INJECTION. SINGLE-DOSE PREFILLED SYRINGES THAT CONTAIN 480 MCG OF TBO-FILGRASTIM AT A FILL VOLUME OF 0.8 ML. MUST BE REFRIGERATED. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FILGRASTIM INJECTION GRANIX |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |